Adagene_Logo_GNW.png
Adagene Reports Six Month Financial Results for 2023 and Provides Corporate Update
31 août 2023 07h32 HE | Adagene Inc.
- Best-in-class anti-CTLA-4 candidates designed for more than 30-fold increase in therapeutic index, addressing patient populations where CTLA-4-mediated Treg depletion is essential for efficacy – -...